About Acme Formulation Private Limited
Data last updated: 17 December 2025
Acme Formulation Private Limited is a private limited company based in Himachal Pradesh, Himachal Pradesh, India, a subsidiary of Pagac Ariane Pte Ltd. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 21 June 2004, the company has been in operation for over 22 years.
Registered with ROC Himachal Pradesh under CIN U24230HP2004PTC027223.
Capital: an authorised share capital of ₹18 Cr and a paid-up capital of ₹10.25 Cr. It is led by directors including Viral Shah and Aswin Vikram.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Village Chowkiwalatehsil Nalagarh Distt Solan, Himachal Pradesh, Himachal Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹577 Cr, a decline of 2% compared to the previous year.
The company has a workforce of approximately 601 employees as per the latest available data. It operates as a subsidiary of Pagac Ariane Pte Ltd. Its group structure includes 4 subsidiaries.
The company is associated with 1 brand - Acme Generics. As per MCA filings, the company has open charges of ₹115.72 Cr and satisfied charges of ₹202.58 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acmegenerics.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressVillage Chowkiwalatehsil Nalagarh Distt Solan, Himachal Pradesh, Himachal Pradesh, India
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Acme Formulation Private Limited
Acme Formulation Private Limited operates one associated brand: Acme Generics. These brands represent Acme Formulation Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Solid and liquid formulations are manufactured as a CDMO focus. | acmegenerics.in |
Competitors & Alternatives of Acme Formulation Private Limited
Brands and companies operating in the same space as Acme Formulation Private Limited include Abzena, Syngene, Grand River Aseptic Manufacturing and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Abzena
|
Provider of antibody discovery, cell line development, and bio analytics services | Cambridge, United Kingdom, United Kingdom | 2001 |
Syngene
|
Provider of contract research and manufacturing services for both small molecules and biologics | Bengaluru, India, India | 1993 |
Grand River Aseptic Manufacturing
|
Sterile parenteral CDMO services for development and manufacturing are offered. | Grand Rapids, United States, United States | 2010 |
Patheon
|
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | Durham, United States, United States | 1974 |
Panacea Biotec
|
Developer of biosimilars, vaccines and natural products | Ambala, India, India | 1984 |
Piramal Group
|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | Mumbai, India, India | 1984 |
Maravai Life Sciences
|
Provides enabling tools and services in the life sciences research and bio-production industries | San Diego, United States, United States | 2014 |
LakePharma
|
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | Belmont, United States, United States | 2009 |
Insud Pharma
|
Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. | Madrid, Spain, Spain | 1977 |
Business Activity of Acme Formulation Private Limited
Acme Formulation Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Acme Formulation Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Acme Formulation Private Limited
Acme Formulation Private Limited is audited by S. R. Batliboi & Co. LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S. R. Batliboi & Co. LLP | Locked | Locked | Locked |
Complete auditor history for Acme Formulation Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Acme Formulation Private Limited
Acme Formulation Private Limited is currently managed by 4 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Viral Shah
Also directs:
Ambriel Life Sciences Llp, Acme Generics Private Limited, Tekno Touch Private Limited and 3 more
|
Managing Director | 24 Jan 2007 | 19 Years 6 Months | Current |
|
Aswin Vikram
Also directs:
Nuvama Wealth Management Limited, Pagac Advisors India Private Limited, Alternicq Limited and 4 more
|
Director | 04 Oct 2021 | 4 Years 10 Months | Current |
|
Vikas Sharma
Also directs:
Acme Generics Private Limited, Ace Testing Solutions Private Limited, Ace Invest Private Limited and 1 more
|
Whole-Time Director | 29 Jul 2020 | 6 Years 0 Months | Current |
| Nikhil Kumar Srivastava | Director | 04 Oct 2021 | 4 Years 10 Months | Current |
Financials of Acme Formulation Private Limited FY 2024 filings available
Acme Formulation Private Limited reported revenue of ₹577 Cr (down 2.00% YoY) for FY 2025.
Ten-year financial statements for Acme Formulation Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Acme Formulation Private Limited
Shareholding and ownership data for Acme Formulation Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Acme Formulation Private Limited
Acme Formulation Private Limited has 4 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Acme Formulation Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Acme Generics Private Limited | U24100PB2021PTC056566 | Locked |
| Ace Testing Solutions Private Limited | U74140HP2009PTC031248 | Locked |
| Ace Invest Private Limited | U74900CH2013PTC034318 | Locked |
| Immacule Lifesciences Private Limited | U74900HP2010PTC031676 | Locked |
Showing major subsidiaries. Total: 4.
Charges & Borrowings of Acme Formulation Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Aug 2021 | State Bank of India | ₹50.72 Cr | Open |
| 17 Jan 2020 | Hdfc Bank Limited | ₹30.5 Cr | Open |
| 17 Jan 2020 | Hdfc Bank Limited | ₹8.5 Cr | Open |
| 17 Jan 2020 | Hdfc Bank Limited | ₹26 Cr | Open |
| 23 Nov 2016 | Hdfc Bank Limited | ₹25.5 Cr | Satisfied |
Total charge records: 18 View all charges
Employees and EPFO Compliance at Acme Formulation Private Limited
Acme Formulation Private Limited has a workforce of 601 employees as of Mar 28, 2024.
Employee and EPFO history for Acme Formulation Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Acme Formulation Private Limited
GST registrations and filing compliance for Acme Formulation Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Acme Formulation Private Limited
Credit ratings, litigation, and regulatory alerts for Acme Formulation Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acme Formulation Private Limited
MSME payment history for Acme Formulation Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acme Formulation Private Limited
Corporate group structure for Acme Formulation Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acme Formulation Private Limited
MCA filings and documents for Acme Formulation Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Acme Formulation Private Limited
Frequently Asked Questions about Acme Formulation Private Limited
Acme Formulation Private Limited is an active private limited company in the pharma sector based in Himachal Pradesh, Himachal Pradesh, India. It was incorporated on 21 June 2004 (22+ years old) and is registered under CIN U24230HP2004PTC027223. The company has 601 employees.
Acme Formulation Private Limited reported revenue of ₹577 Cr for FY 2025 (down 2.00% YoY).
The current directors of Acme Formulation Private Limited are:
- Viral Shah - Managing Director
- Aswin Vikram - Director
- Vikas Sharma - Whole-Time Director
- Nikhil Kumar Srivastava - Director
The primary industry of Acme Formulation Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Acme Formulation Private Limited can be reached at the registered office: Village Chowkiwalatehsil Nalagarh Distt Solan, Himachal Pradesh, Himachal Pradesh, India, or through the website acmegenerics.in.
The authorised capital is ₹18 Cr, and the paid-up capital is ₹10.25 Cr.